CF vs RYTM · P/E 12, rev $5.94B vs rev $130.1M
CF Industries Holdings Inc (CF) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
CF currently screens at market cap $14.98B and trailing P/E 12.2. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the CF and RYTM stock pages for the full models.
Not investment advice.